TEAS RF New Application

NK-92

NantKwest, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)

Trademark/Service Mark Application, Principal Register

Serial Number: 87701224
Filing Date: 11/29/2017

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 87701224
MARK INFORMATION
*MARK NK-92
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT NK-92
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK NantKwest, Inc.
*STREET 9920 Jefferson Boulevard
*CITY Culver City
*STATE
(Required for U.S. applicants)
California
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
90232
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 001 
*IDENTIFICATION Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 00/00/1994
       FIRST USE IN COMMERCE DATE At least as early as 00/00/1994
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-502275098-20171024134154452464_._Cl.1_specimen_NK-92.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT17\IMAGEOUT17\877\012\87701224\xml1\RFA0003.JPG
       SPECIMEN DESCRIPTION Photograph of the mark displayed on the product label affixed to the product container
INTERNATIONAL CLASS 001 
*IDENTIFICATION Kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 00/00/2008
       FIRST USE IN COMMERCE DATE At least as early as 00/00/2008
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-1-502275098-20171024134154452464_._Cl.1_specimen_NK-92.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT17\IMAGEOUT17\877\012\87701224\xml1\RFA0004.JPG
       SPECIMEN DESCRIPTION Photograph of the mark displayed on the product label affixed to the product container
INTERNATIONAL CLASS 005 
*IDENTIFICATION Cells for clinical, medical, veterinary, and therapeutic purposes; cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cells, namely, natural killer cells, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 00/00/1994
       FIRST USE IN COMMERCE DATE At least as early as 00/00/1994
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-1-502275098-20171024134154452464_._Cl.5_specimen_NK-92.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT17\IMAGEOUT17\877\012\87701224\xml1\RFA0005.JPG
       SPECIMEN DESCRIPTION Photograph of the mark displayed on the product label affixed to the product container
INTERNATIONAL CLASS 005 
*IDENTIFICATION Kits comprised of cells, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 00/00/2008
       FIRST USE IN COMMERCE DATE At least as early as 00/00/2008
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-2-502275098-20171024134154452464_._Cl.5_specimen_NK-92.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT17\IMAGEOUT17\877\012\87701224\xml1\RFA0006.JPG
       SPECIMEN DESCRIPTION Photograph of the mark displayed on the product label affixed to the product container
INTERNATIONAL CLASS 042 
*IDENTIFICATION Research in the field of cancer; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine, therapeutics and research related thereto
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 00/00/2005
       FIRST USE IN COMMERCE DATE At least as early as 00/00/2005
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-502275098-20171025165318769097_._CL.42_specimen_NK-92.pdf
       CONVERTED PDF FILE(S)
       (5 pages)
\\TICRS\EXPORT17\IMAGEOUT17\877\012\87701224\xml1\RFA0007.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\877\012\87701224\xml1\RFA0008.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\877\012\87701224\xml1\RFA0009.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\877\012\87701224\xml1\RFA0010.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\877\012\87701224\xml1\RFA0011.JPG
       SPECIMEN DESCRIPTION Printout from Applicant's website displaying the mark in connection with the services
ATTORNEY INFORMATION
NAME Alicia M. Passerin
ATTORNEY DOCKET NUMBER NKW-19
FIRM NAME Leech Tishman Fuscaldo & Lampl
STREET 525 William Penn Place, 28th Floor
CITY Pittsburgh
STATE Pennsylvania
COUNTRY United States
ZIP/POSTAL CODE 15219
PHONE 412-261-1600
FAX 412-227-5551
EMAIL ADDRESS ipdocket@leechtishman.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Alan G. Towner, Michael D. Lazzara, Charles M. Yeomans, Christopher J. Owens
CORRESPONDENCE INFORMATION
NAME Alicia M. Passerin
FIRM NAME Leech Tishman Fuscaldo & Lampl
STREET 525 William Penn Place, 28th Floor
CITY Pittsburgh
STATE Pennsylvania
COUNTRY United States
ZIP/POSTAL CODE 15219
PHONE 412-261-1600
FAX 412-227-5551
*EMAIL ADDRESS ipdocket@leechtishman.com; apasserin@leechtishman.com; dpeake@leechtishman.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 825
*TOTAL FEE PAID 825
SIGNATURE INFORMATION
SIGNATURE /Alicia M. Passerin/
SIGNATORY'S NAME Alicia M. Passerin
SIGNATORY'S POSITION Attorney of Record, PA Bar Member
SIGNATORY'S PHONE NUMBER 412-261-1600
DATE SIGNED 11/29/2017



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)


Trademark/Service Mark Application, Principal Register

Serial Number: 87701224
Filing Date: 11/29/2017

To the Commissioner for Trademarks:

MARK: NK-92 (Standard Characters, see mark)
The literal element of the mark consists of NK-92.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, NantKwest, Inc., a corporation of Delaware, having an address of
      9920 Jefferson Boulevard
      Culver City, California 90232
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 001:  Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research

In International Class 001, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/1994, and first used in commerce at least as early as 00/00/1994, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Photograph of the mark displayed on the product label affixed to the product container.

Original PDF file:
SPE0-502275098-20171024134154452464_._Cl.1_specimen_NK-92.pdf
Converted PDF file(s) (1 page)
Specimen File1

       International Class 001:  Kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes

In International Class 001, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/2008, and first used in commerce at least as early as 00/00/2008, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Photograph of the mark displayed on the product label affixed to the product container.

Original PDF file:
SPE0-1-502275098-20171024134154452464_._Cl.1_specimen_NK-92.pdf
Converted PDF file(s) (1 page)
Specimen File1

       International Class 005:  Cells for clinical, medical, veterinary, and therapeutic purposes; cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cells, namely, natural killer cells, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/1994, and first used in commerce at least as early as 00/00/1994, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Photograph of the mark displayed on the product label affixed to the product container.

Original PDF file:
SPE0-1-502275098-20171024134154452464_._Cl.5_specimen_NK-92.pdf
Converted PDF file(s) (1 page)
Specimen File1

       International Class 005:  Kits comprised of cells, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/2008, and first used in commerce at least as early as 00/00/2008, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Photograph of the mark displayed on the product label affixed to the product container.

Original PDF file:
SPE0-2-502275098-20171024134154452464_._Cl.5_specimen_NK-92.pdf
Converted PDF file(s) (1 page)
Specimen File1

       International Class 042:  Research in the field of cancer; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine, therapeutics and research related thereto

In International Class 042, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/2005, and first used in commerce at least as early as 00/00/2005, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Printout from Applicant's website displaying the mark in connection with the services.

Original PDF file:
SPE0-502275098-20171025165318769097_._CL.42_specimen_NK-92.pdf
Converted PDF file(s) (5 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Specimen File5


The applicant's current Attorney Information:
      Alicia M. Passerin and Alan G. Towner, Michael D. Lazzara, Charles M. Yeomans, Christopher J. Owens of Leech Tishman Fuscaldo & Lampl      525 William Penn Place, 28th Floor
      Pittsburgh, Pennsylvania 15219
      United States
      412-261-1600(phone)
      412-227-5551(fax)
      ipdocket@leechtishman.com (authorized)
The attorney docket/reference number is NKW-19.
The applicant's current Correspondence Information:
      Alicia M. Passerin
      Leech Tishman Fuscaldo & Lampl
      525 William Penn Place, 28th Floor
      Pittsburgh, Pennsylvania 15219
      412-261-1600(phone)
      412-227-5551(fax)
      ipdocket@leechtishman.com;apasserin@leechtishman.com; dpeake@leechtishman.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: /Alicia M. Passerin/   Date: 11/29/2017
Signatory's Name: Alicia M. Passerin
Signatory's Position: Attorney of Record, PA Bar Member
Payment Sale Number: 87701224
Payment Accounting Date: 11/29/2017

Serial Number: 87701224
Internet Transmission Date: Wed Nov 29 13:02:52 EST 2017
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XX-20171129130252602
511-87701224-510f36a5f3e7d60aac25728c1a7
f9675d97d0786057f7479260e14e4679c48784e-
DA-11807-20171129125553454517

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed